BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Anbogen Partners with BeiGene to Launch Global Phase II Trial for Innovative Colorectal Cancer Treatment

Anbogen, a clinical-stage biotech company, announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with Bei...

September 30, 2024 | News

Belief BioMed and AskBio Forge Strategic Collaboration to Advance Liver-Targeted Gene Therapies

Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...

September 26, 2024 | News

Ractigen Therapeutics Reports Positive Clinical Data from ALS-SOD1 Trial of RAG-17

Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced promising clinical data from an Inve...

September 11, 2024 | News

Bambusa Therapeutics Secures $15M in Series Seed Funding to Advance Bispecific Antibody Pipeline

Bambusa Therapeutics Inc., a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory (I&I...

September 10, 2024 | News

Albatroz Therapeutics Joins Johnson & Johnson Innovation – JLABS Singapore to Accelerate Cancer Therapy Development

Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson &...

September 04, 2024 | News

Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology

Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...

September 04, 2024 | News

Thermo Fisher Scientific Expands Asian Operations with New Business Services Center in the Philippines

Thermo Fisher Scientific, the world leader in serving science, has announced the opening of a new Global Business Services Center (GBSC) in the Philippines...

September 03, 2024 | News

LOTTE Holdings Launches New CVC to Propel Innovations in Biopharmaceuticals and Next-Generation Modalities

LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("...

August 29, 2024 | News

CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer

CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...

August 26, 2024 | News

AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME

AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 tria...

August 26, 2024 | News

Finnish Biotech NADMED Secures €3.5M to Transform Vitamin B3 Testing with Groundbreaking NAD Measurement Technology

Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...

August 23, 2024 | News

Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results

New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...

August 21, 2024 | News

NSG BioLabs Partners with Merck Singapore to Elevate Biotech Startups' R&D Capabilities

NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, and the Life Science business of Merck Singapo...

August 15, 2024 | News

Bayer Submits New Drug Application to FDA for Elinzanetant, a Novel Non-Hormonal Treatment for Menopausal Hot Flashes

The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency...

August 02, 2024 | News

Stay Connected